GSA Capital Partners »

Cullinan Oncology shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $283k 27k 10.37
2023-12-31 $104k 10k 10.15

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Blue Owl Capital Holdings
State Street Corporation
Citadel Advisors
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Boothbay Fund Management
Siren

View all funds holding Cullinan Oncology